[Oral diabetes therapy with special reference to a new antidiabetic (Glybenclamid-HB 419)].
D000328:Adult; D000368:Aged; D001645:Biguanides / Q000008:administration & dosage; D055598:Chemical Phenomena; D002621:Chemistry; D003920:Diabetes Mellitus / Q000188:drug therapy*; D004357:Drug Synergism; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D013607:Tablets
D001645:Biguanides; D007004:Hypoglycemic Agents; D013607:Tablets
Orale Diabetes-Therapie unter besonderer Berücksichtigung eines neuen Antidiabetikums (Glybenclamid-HB 419)